---
title: "CareRay, Touchstone, and others establish venture capital partnership enterprises"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/223148978.md"
description: "According to the Qichacha APP, recently, Suzhou Qianrong Qingrun Venture Capital Partnership was established with a capital contribution of 200 million yuan, and its business scope includes: venture capital. Qichacha's equity penetration shows that this enterprise is jointly held by CareRay, Touchstone, and others"
datetime: "2024-12-24T02:23:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/223148978.md)
  - [en](https://longbridge.com/en/news/223148978.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/223148978.md)
generator: "portal-rs"
---

# CareRay, Touchstone, and others establish venture capital partnership enterprises

According to the Qichacha APP, recently, Suzhou Qianrong Qingrun Venture Capital Partnership was established with a capital contribution of 200 million yuan. The business scope includes: venture capital. Qichacha's equity penetration shows that this enterprise is jointly held by CareRay, Touchstone, and others

### Related Stocks

- [688607.CN](https://longbridge.com/en/quote/688607.CN.md)
- [688013.CN](https://longbridge.com/en/quote/688013.CN.md)

## Related News & Research

- [REG - American Century Inv Spire Healthcare Grp - Form 8.3 - Spire Healthcare Group PLC](https://longbridge.com/en/news/298045178.md)
- [Frontieras North America’s Leaders Bring Core Expertise, Background as Company Moves Toward Commercial Execution](https://longbridge.com/en/news/298054978.md)
- [REG - EDX Medical Group - Director/PDMR shareholdings in the Company](https://longbridge.com/en/news/298058813.md)
- [Keensight Capital partner says market underestimates AI upside for European healthcare champions in CNBC interview](https://longbridge.com/en/news/297808235.md)
- [Volunteer at TechCrunch Founder Summit in Boston](https://longbridge.com/en/news/297919234.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**